G
The startup develops oral probiotic supplements that utilize specific strains of probiotics to enhance glycemic regulation in individuals with prediabetes. By targeting the gut microbiota, the company aims to improve long-term blood sugar control and reduce the risk of progression to diabetes.
Updated 3 months ago
Funding
$920K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops oral probiotic supplements that utilize specific strains of probiotics to enhance glycemic regulation in individuals with prediabetes. By targeting the gut microbiota, the company aims to improve long-term blood sugar control and reduce the risk of progression to diabetes.